Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$22.3 - $36.29 $110,964 - $180,579
-4,976 Reduced 31.21%
10,966 $251,000
Q2 2024

Jul 29, 2024

SELL
$16.07 - $31.84 $3.41 Million - $6.76 Million
-212,273 Reduced 93.01%
15,942 $460,000
Q1 2024

Apr 29, 2024

BUY
$17.13 - $26.91 $3.69 Million - $5.79 Million
215,170 Added 1649.44%
228,215 $4.71 Million
Q4 2023

Feb 07, 2024

BUY
$21.58 - $29.5 $26,759 - $36,580
1,240 Added 10.5%
13,045 $352,000
Q3 2023

Nov 02, 2023

SELL
$25.8 - $39.97 $34,133 - $52,880
-1,323 Reduced 10.08%
11,805 $349,000
Q2 2023

Aug 07, 2023

BUY
$20.94 - $38.01 $56,914 - $103,311
2,718 Added 26.11%
13,128 $469,000
Q1 2023

May 09, 2023

SELL
$22.92 - $33.76 $44,602 - $65,696
-1,946 Reduced 15.75%
10,410 $244,000
Q4 2022

Feb 09, 2023

SELL
$25.44 - $59.78 $275,184 - $646,640
-10,817 Reduced 46.68%
12,356 $336,000
Q3 2022

Nov 09, 2022

SELL
$43.66 - $61.0 $74,658 - $104,310
-1,710 Reduced 6.87%
23,173 $1.25 Million
Q2 2022

Aug 10, 2022

BUY
$28.82 - $77.35 $124,646 - $334,538
4,325 Added 21.04%
24,883 $1 Million
Q1 2022

May 09, 2022

SELL
$48.25 - $100.49 $64,799 - $134,958
-1,343 Reduced 6.13%
20,558 $1.36 Million
Q4 2021

Feb 09, 2022

SELL
$88.71 - $120.43 $671,002 - $910,932
-7,564 Reduced 25.67%
21,901 $2.19 Million
Q3 2021

Nov 09, 2021

SELL
$98.77 - $132.17 $370,980 - $496,430
-3,756 Reduced 11.31%
29,465 $3.68 Million
Q2 2021

Aug 10, 2021

BUY
$109.77 - $165.68 $186,169 - $280,993
1,696 Added 5.38%
33,221 $4.13 Million
Q1 2021

May 10, 2021

BUY
$127.04 - $179.1 $120,942 - $170,503
952 Added 3.11%
31,525 $4.81 Million
Q4 2020

Feb 08, 2021

BUY
$99.96 - $135.93 $134,246 - $182,553
1,343 Added 4.59%
30,573 $3.94 Million
Q3 2020

Nov 06, 2020

SELL
$80.32 - $111.8 $169,234 - $235,562
-2,107 Reduced 6.72%
29,230 $3.27 Million
Q2 2020

Aug 05, 2020

BUY
$60.49 - $97.5 $1.03 Million - $1.66 Million
17,055 Added 119.42%
31,337 $2.54 Million
Q1 2020

May 12, 2020

BUY
$59.04 - $88.81 $35,660 - $53,641
604 Added 4.42%
14,282 $994,000
Q4 2019

Feb 05, 2020

BUY
$59.49 - $82.78 $20,821 - $28,973
350 Added 2.63%
13,678 $1.07 Million
Q3 2019

Nov 13, 2019

SELL
$62.59 - $110.3 $324,904 - $572,567
-5,191 Reduced 28.03%
13,328 $851,000
Q2 2019

Aug 12, 2019

BUY
$63.94 - $91.11 $1.18 Million - $1.69 Million
18,519 New
18,519 $1.6 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.